Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global End Stage Renal Disease market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
End Stage Renal Disease market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The End Stage Renal Disease market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the End Stage Renal Disease products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of End Stage Renal Disease products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the End Stage Renal Disease market.
To learn more about this report
Increasing research and development spending on End Stage Renal Disease development has been the leading industry trend of End Stage Renal Disease market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Transplantation, Dialysis, Other |
| By Application Outlook | Public Hospitals, Private Hospitals, Other |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Nipro Corporation, Fresenius Medical Care, Baxter International, Inc., Medtronic, B. Braun Melsungen AG, BD, Asahi Kasei Medical Co., Ltd., Cantel Medical, Nikkiso, JMS |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 End Stage Renal Disease Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global End Stage Renal Disease Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global End Stage Renal Disease Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global End Stage Renal Disease Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Transplantation
4.2.2 Dialysis
4.2.3 Other
4.4 Type Comparison Matrix
4.5 Global End Stage Renal Disease Market Attractiveness, By Type
5 Global End Stage Renal Disease Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global End Stage Renal Disease Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Public Hospitals
5.3.2 Private Hospitals
5.3.3 Other
5.4 Application Comparison Matrix
5.5 Global End Stage Renal Disease Market Attractiveness, by Application
6 Global End Stage Renal Disease Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global End Stage Renal Disease Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global End Stage Renal Disease Market Attractiveness, by Region
8 North America End Stage Renal Disease Market Analysis and Forecast
8.1 Key Findings
8.2 North America End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Transplantation
8.2.2 Dialysis
8.2.3 Other
8.3 North America End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Public Hospitals
8.3.2 Private Hospitals
8.3.3 Other
8.4 North America End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America End Stage Renal Disease Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe End Stage Renal Disease Market Analysis and Forecast
9.1 Key Findings
9.2 Europe End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Transplantation
9.2.2 Dialysis
9.2.3 Other
9.3 Europe End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Public Hospitals
9.3.2 Private Hospitals
9.3.3 Other
9.4 Europe End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe End Stage Renal Disease Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific End Stage Renal Disease Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Transplantation
10.2.2 Dialysis
10.2.3 Other
10.3 Asia Pacific End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Public Hospitals
10.3.2 Private Hospitals
10.3.3 Other
10.4 Asia Pacific End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific End Stage Renal Disease Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America End Stage Renal Disease Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Transplantation
11.2.2 Dialysis
11.2.3 Other
11.3 Latin America End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Public Hospitals
11.3.2 Private Hospitals
11.3.3 Other
11.4 Latin America End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America End Stage Renal Disease Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) End Stage Renal Disease Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Transplantation
12.2.2 Dialysis
12.2.3 Other
12.3 Middle East & Africa (MEA) End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Public Hospitals
12.3.2 Private Hospitals
12.3.3 Other
12.4 Middle East & Africa (MEA) End Stage Renal Disease Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) End Stage Renal Disease Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Nipro Corporation
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Fresenius Medical Care
13.3.3 Baxter International
13.3.4 Inc.
13.3.5 Medtronic
13.3.6 B. Braun Melsungen AG
13.3.7 BD
13.3.8 Asahi Kasei Medical Co.
13.3.9 Ltd.
13.3.10 Cantel Medical
13.3.11 Nikkiso
13.3.12 JMS
14 Key Takeaways
Choose License Type